Related Experiment Video
Updated: May 21, 2026
09:27
Methodology for the Efficient Generation of Fluorescently Tagged Vaccinia Virus Proteins
Published on: January 17, 2014
Easy and efficient protocols for working with recombinant vaccinia virus MVA
Melanie Kremer1, Asisa Volz, Joost H C M Kreijtz
1Institute for Infectious Diseases and Zoonoses, University of Munich LMU, Munich, Germany.
Methods in Molecular Biology (Clifton, N.J.)
|June 13, 2012
Summary
Modified vaccinia virus Ankara (MVA) offers a safe, effective vector for gene expression and vaccine development. This chapter details protocols for generating, purifying, and quality-controlling MVA vectors for research and clinical use.
Area of Science:
- Virology
- Molecular Biology
- Biotechnology
Background:
- Modified vaccinia virus Ankara (MVA) is a highly attenuated, replication-deficient vaccinia virus strain.
- MVA is increasingly utilized as a vector for recombinant gene expression and vaccine development.
- MVA offers significant safety advantages over conventional vaccinia viruses.
Purpose of the Study:
- To provide state-of-the-art protocols for the generation, amplification, and purification of recombinant MVA viruses.
- To detail methodologies for rigorous quality control of MVA vectors.
- To facilitate the use of MVA vectors in research, including clinical evaluation.
Main Methods:
- Established procedures for genetic engineering of MVA.
- Industrial-scale virus production methods.
- Rigorous quality control assays for vector characterization.
Main Results:
- MVA vectors can be handled under Biosafety Level 1 conditions.
- Numerous recombinant MVA vaccines have demonstrated immunogenicity and protective efficacy in preclinical and clinical studies.
- Protocols ensure high-quality MVA vector production.
Conclusions:
- MVA is a versatile and safe viral vector for diverse applications in research and medicine.
- Standardized protocols and quality control are crucial for reliable MVA vector development.
- MVA holds significant promise for future vaccine development and gene therapy.
